StockData
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Intercure Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$4.46−0.11 (-2.41%)

Close on Oct 19, 2026

Intercure Ltd. revenue by segment

No segment breakdown reported

Intercure does not break out revenue by segment, region or product in the tagged data of its filings for this period type.